Logo image of REC.MI

RECORDATI INDUSTRIA CHIMICA (REC.MI) Stock Fundamental Analysis

Europe - BIT:REC - IT0003828271 - Common Stock

53.6 EUR
-0.3 (-0.56%)
Last: 9/15/2025, 10:01:45 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to REC. REC was compared to 49 industry peers in the Pharmaceuticals industry. While REC is still in line with the averages on profitability rating, there are concerns on its financial health. REC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

REC had positive earnings in the past year.
REC had a positive operating cash flow in the past year.
In the past 5 years REC has always been profitable.
Each year in the past 5 years REC had a positive operating cash flow.
REC.MI Yearly Net Income VS EBIT VS OCF VS FCFREC.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

REC has a Return On Assets of 7.87%. This is in the better half of the industry: REC outperforms 67.35% of its industry peers.
REC has a Return On Equity of 21.77%. This is in the better half of the industry: REC outperforms 73.47% of its industry peers.
The Return On Invested Capital of REC (12.31%) is better than 63.27% of its industry peers.
REC had an Average Return On Invested Capital over the past 3 years of 12.56%. This is below the industry average of 15.25%.
Industry RankSector Rank
ROA 7.87%
ROE 21.77%
ROIC 12.31%
ROA(3y)8.39%
ROA(5y)10.39%
ROE(3y)21.82%
ROE(5y)24.25%
ROIC(3y)12.56%
ROIC(5y)14.53%
REC.MI Yearly ROA, ROE, ROICREC.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With a decent Profit Margin value of 16.42%, REC is doing good in the industry, outperforming 67.35% of the companies in the same industry.
In the last couple of years the Profit Margin of REC has declined.
With a decent Operating Margin value of 26.76%, REC is doing good in the industry, outperforming 75.51% of the companies in the same industry.
REC's Operating Margin has declined in the last couple of years.
REC's Gross Margin of 67.79% is in line compared to the rest of the industry. REC outperforms 46.94% of its industry peers.
In the last couple of years the Gross Margin of REC has remained more or less at the same level.
Industry RankSector Rank
OM 26.76%
PM (TTM) 16.42%
GM 67.79%
OM growth 3Y-4.02%
OM growth 5Y-2.11%
PM growth 3Y-10.03%
PM growth 5Y-6.5%
GM growth 3Y-2.14%
GM growth 5Y-0.62%
REC.MI Yearly Profit, Operating, Gross MarginsREC.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), REC is creating some value.
Compared to 1 year ago, REC has about the same amount of shares outstanding.
REC has more shares outstanding than it did 5 years ago.
REC has a worse debt/assets ratio than last year.
REC.MI Yearly Shares OutstandingREC.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
REC.MI Yearly Total Debt VS Total AssetsREC.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 3.68 indicates that REC is not in any danger for bankruptcy at the moment.
With a Altman-Z score value of 3.68, REC perfoms like the industry average, outperforming 55.10% of the companies in the same industry.
REC has a Debt/Equity ratio of 1.16. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of REC (1.16) is worse than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Altman-Z 3.68
ROIC/WACC1.69
WACC7.3%
REC.MI Yearly LT Debt VS Equity VS FCFREC.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.47 indicates that REC should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.47, REC is in the better half of the industry, outperforming 61.22% of the companies in the same industry.
A Quick Ratio of 1.01 indicates that REC should not have too much problems paying its short term obligations.
REC has a Quick ratio (1.01) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.01
REC.MI Yearly Current Assets VS Current LiabilitesREC.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.75% over the past year.
REC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.74% yearly.
Looking at the last year, REC shows a quite strong growth in Revenue. The Revenue has grown by 11.51% in the last year.
REC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.58% yearly.
EPS 1Y (TTM)10.75%
EPS 3Y3.03%
EPS 5Y2.74%
EPS Q2Q%-10.39%
Revenue 1Y (TTM)11.51%
Revenue growth 3Y14.01%
Revenue growth 5Y9.58%
Sales Q2Q%11.43%

3.2 Future

REC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.78% yearly.
REC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.17% yearly.
EPS Next Y13.02%
EPS Next 2Y13.22%
EPS Next 3Y11.89%
EPS Next 5Y12.78%
Revenue Next Year13.6%
Revenue Next 2Y10.14%
Revenue Next 3Y8.87%
Revenue Next 5Y8.17%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
REC.MI Yearly Revenue VS EstimatesREC.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
REC.MI Yearly EPS VS EstimatesREC.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 27.21, REC can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of REC is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.30. REC is around the same levels.
With a Price/Forward Earnings ratio of 17.00, REC is valued on the expensive side.
REC's Price/Forward Earnings ratio is in line with the industry average.
REC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 27.21
Fwd PE 17
REC.MI Price Earnings VS Forward Price EarningsREC.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

REC's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.64
REC.MI Per share dataREC.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates REC does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.09
PEG (5Y)9.95
EPS Next 2Y13.22%
EPS Next 3Y11.89%

4

5. Dividend

5.1 Amount

REC has a Yearly Dividend Yield of 2.33%.
REC's Dividend Yield is a higher than the industry average which is at 3.04.
REC's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.33%

5.2 History

The dividend of REC has a limited annual growth rate of 5.70%.
Dividend Growth(5Y)5.7%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

REC pays out 64.48% of its income as dividend. This is not a sustainable payout ratio.
The dividend of REC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP64.48%
EPS Next 2Y13.22%
EPS Next 3Y11.89%
REC.MI Yearly Income VS Free CF VS DividendREC.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
REC.MI Dividend Payout.REC.MI Dividend Payout, showing the Payout Ratio.REC.MI Dividend Payout.PayoutRetained Earnings

RECORDATI INDUSTRIA CHIMICA

BIT:REC (9/15/2025, 10:01:45 AM)

53.6

-0.3 (-0.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)07-29 2025-07-29
Earnings (Next)11-11 2025-11-11
Inst Owners28.5%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.21B
Analysts74.67
Price Target60.43 (12.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.33%
Yearly Dividend1.23
Dividend Growth(5Y)5.7%
DP64.48%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.01%
PT rev (3m)2.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.69%
EPS NY rev (3m)-1.69%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE 27.21
Fwd PE 17
P/S 4.52
P/FCF N/A
P/OCF 19.5
P/B 5.99
P/tB N/A
EV/EBITDA 15.64
EPS(TTM)1.97
EY3.68%
EPS(NY)3.15
Fwd EY5.88%
FCF(TTM)-1.43
FCFYN/A
OCF(TTM)2.75
OCFY5.13%
SpS11.86
BVpS8.94
TBVpS-6.58
PEG (NY)2.09
PEG (5Y)9.95
Profitability
Industry RankSector Rank
ROA 7.87%
ROE 21.77%
ROCE 16.15%
ROIC 12.31%
ROICexc 13.4%
ROICexgc 85.95%
OM 26.76%
PM (TTM) 16.42%
GM 67.79%
FCFM N/A
ROA(3y)8.39%
ROA(5y)10.39%
ROE(3y)21.82%
ROE(5y)24.25%
ROIC(3y)12.56%
ROIC(5y)14.53%
ROICexc(3y)13.61%
ROICexc(5y)15.94%
ROICexgc(3y)107.06%
ROICexgc(5y)120.52%
ROCE(3y)16.51%
ROCE(5y)18.96%
ROICexcg growth 3Y-16.79%
ROICexcg growth 5Y-5.99%
ROICexc growth 3Y-13.14%
ROICexc growth 5Y-5.73%
OM growth 3Y-4.02%
OM growth 5Y-2.11%
PM growth 3Y-10.03%
PM growth 5Y-6.5%
GM growth 3Y-2.14%
GM growth 5Y-0.62%
F-Score6
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Debt/EBITDA 2.54
Cap/Depr 464.32%
Cap/Sales 35.24%
Interest Coverage 7.76
Cash Conversion 67.5%
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 1.01
Altman-Z 3.68
F-Score6
WACC7.3%
ROIC/WACC1.69
Cap/Depr(3y)284.95%
Cap/Depr(5y)216.99%
Cap/Sales(3y)19.98%
Cap/Sales(5y)14.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.75%
EPS 3Y3.03%
EPS 5Y2.74%
EPS Q2Q%-10.39%
EPS Next Y13.02%
EPS Next 2Y13.22%
EPS Next 3Y11.89%
EPS Next 5Y12.78%
Revenue 1Y (TTM)11.51%
Revenue growth 3Y14.01%
Revenue growth 5Y9.58%
Sales Q2Q%11.43%
Revenue Next Year13.6%
Revenue Next 2Y10.14%
Revenue Next 3Y8.87%
Revenue Next 5Y8.17%
EBIT growth 1Y11.3%
EBIT growth 3Y9.43%
EBIT growth 5Y7.27%
EBIT Next Year44.75%
EBIT Next 3Y18.7%
EBIT Next 5Y14.63%
FCF growth 1Y-168.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.39%
OCF growth 3Y5.01%
OCF growth 5Y12.33%